{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:02:37Z","timestamp":1791925357625,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"EPSRC Centre for Doctoral Training in Health Data Science","award":["EP\/S02428X\/1"],"award-info":[{"award-number":["EP\/S02428X\/1"]}]},{"name":"Oxford-Bristol Myers Squibb Fellowship","award":["R39207\/CN063"],"award-info":[{"award-number":["R39207\/CN063"]}]},{"name":"British Heart Foundation Oxford Centre for Research Excellence","award":["RE\/18\/3\/34214"],"award-info":[{"award-number":["RE\/18\/3\/34214"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/ICRF\/24\/26111"],"award-info":[{"award-number":["FS\/ICRF\/24\/26111"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214290\/Z\/18\/Z"],"award-info":[{"award-number":["214290\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EPSRC project CompBioMed X","award":["EP\/X019446\/1"],"award-info":[{"award-number":["EP\/X019446\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cardiometabolic disturbances play a central role in the pathogenesis of heart failure with preserved ejection fraction (HFpEF). Due to its complexity, HFpEF is a challenging condition to treat, making phenotype-specific disease management a promising approach. However, HFpEF phenotypes are heterogenous and there is a lack of detailed evidence on the different, sex-specific profiles of cardiometabolic multimorbidity and metabolic syndrome present in HFpEF.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective, modified cross-sectional study examining a subset of participants in the UK Biobank, an ongoing multi-centre prospective cohort study in the United Kingdom. We defined HFpEF as a record of a heart failure diagnosis using ICD-10 code I50, coupled with a left ventricular ejection fraction (LVEF)\u2009\u2265\u200950% derived from cardiac magnetic resonance (CMR) imaging. We examined sex-specific differences in cardiometabolic comorbidity burden and metabolic syndrome, performed latent class analysis (LCA) to identify distinct clusters of patients based on their cardiometabolic profile, and compared CMR imaging-derived parameters of left ventricular function at rest in the different clusters identified to reflect possible differences in adverse cardiac remodelling.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We ascertained HFpEF in 445 participants, of which 299 (67%) were men and 146 (33%) women. The median age was 70\u00a0years old (interquartile range: [66.0\u201374.0]). A combination of hypertension and obesity was the most prevalent cardiometabolic pattern both in men and women with HFpEF. Most men had 2\u20133 clinical cardiometabolic comorbidities while most women had 1\u20132, despite a similar metabolic syndrome profile (<jats:italic>p<\/jats:italic>\u2009=\u20090.05). LCA revealed three distinct, clinically relevant phenogroups, namely (1) a most male and multimorbid group (n\u2009=\u2009117); (2) a group with a high prevalence of severe obesity, abnormal waist circumference and with the highest relative proportion of females (n\u2009=\u2009116); and finally (3) a group with an apparently lower comorbidity burden aside from hypertension (n\u2009=\u2009212). There were significant differences in clinical measurements and medication across the three phenogroups identified. Cardiac output at rest was significantly higher in group 2 vs. group 3 (males: median 5.6 L\/min vs. 5.2 L\/min, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05; females: 5.1 L\/min vs. 4.4 L\/min, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Absolute global longitudinal strain was significantly lower in women in group 1 vs. group 2 (\u221217.6% vs. \u221218.5%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Women with cardiometabolic HFpEF had a lower comorbidity burden compared to men despite a similar metabolic syndrome profile. Based on patients\u2019 cardiometabolic profile, we identified three distinct subgroups which differed in body shape and mass, lipid biomarker and medication profile, as well as in cardiac output at rest both in men and women. These factors may affect disease trajectory, treatment options and outcomes in those subgroups. Subject to further validation, our findings provide a refined characterisation of the cardiometabolic HFpEF phenotype, contributing towards a better understanding of the condition to enable phenotype-specific disease management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Graphical abstract<\/jats:title>\n          <\/jats:sec>","DOI":"10.1186\/s12933-025-02788-4","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:39:17Z","timestamp":1749047957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank"],"prefix":"10.1186","volume":"24","author":[{"given":"Ambre","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Monfeuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramneek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"5\u20136","key":"2788_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","volume":"2","author":"PL Huang","year":"2009","unstructured":"Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5\u20136):231\u20137. https:\/\/doi.org\/10.1242\/dmm.001180.","journal-title":"Dis Model Mech"},{"issue":"10","key":"2788_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus WJ, Zile MR. From systemic inflammation to myocardial fibrosis. Circ Res. 2021;128(10):1451\u201367. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.318159.","journal-title":"Circ Res"},{"issue":"3","key":"2788_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s44161-022-00032-w","volume":"1","author":"GG Schiattarella","year":"2022","unstructured":"Schiattarella GG, Alcaide P, Condorelli G, Gillette TG, Heymans S, Jones EAV, Kallikourdis M, Lichtman A, Marelli-Berg F, Shah SJ, Thorp EB, Hill JA. Immunometabolic mechanisms of heart failure with preserved ejection fraction. Nat Cardiovasc Res. 2022;1(3):211\u201322. https:\/\/doi.org\/10.1038\/s44161-022-00032-w.","journal-title":"Nat Cardiovasc Res"},{"issue":"5","key":"2788_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11897-016-0298-4","volume":"13","author":"H von Bibra","year":"2016","unstructured":"von Bibra H, Paulus W, St. John Sutton M. Cardiometabolic syndrome and increased risk of heart failure. Curr Heart Fail Rep. 2016;13(5):219\u201329. https:\/\/doi.org\/10.1007\/s11897-016-0298-4.","journal-title":"Curr Heart Fail Rep"},{"issue":"10120","key":"2788_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(17)32520-5","volume":"391","author":"N Conrad","year":"2018","unstructured":"Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, Allison M, Hemingway H, Cleland JG, McMurray JJV, Rahimi K. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(17)32520-5.","journal-title":"Lancet"},{"issue":"17","key":"2788_CR6","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272\u201387. https:\/\/doi.org\/10.1093\/cvr\/cvac013.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2788_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","volume":"138","author":"AL Beale","year":"2018","unstructured":"Beale AL, Meyer P, Marwick TH, Lam CSP, Kaye DM. Sex differences in cardiovascular pathophysiology. Circulation. 2018;138(2):198\u2013205. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.034271.","journal-title":"Circulation"},{"issue":"2","key":"2788_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10741-019-09824-y","volume":"25","author":"A De Bellis","year":"2020","unstructured":"De Bellis A, De Angelis G, Fabris E, Cannat\u00e0 A, Merlo M, Sinagra G. Gender-related differences in heart failure: beyond the \u201cone-size-fits-all\u201d paradigm. Heart Fail Rev. 2020;25(2):245\u201355. https:\/\/doi.org\/10.1007\/s10741-019-09824-y.","journal-title":"Heart Fail Rev"},{"issue":"47","key":"2788_CR9","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehz835","volume":"40","author":"CSP Lam","year":"2019","unstructured":"Lam CSP, Arnott C, Beale AL, Chandramouli C, Hilfiker-Kleiner D, Kaye DM, Ky B, Santema BT, Sliwa K, Voors AA. Sex differences in heart failure. Eur Heart J. 2019;40(47):3859\u20133868c. https:\/\/doi.org\/10.1093\/eurheartj\/ehz835.","journal-title":"Eur Heart J"},{"issue":"3","key":"2788_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.36628\/ijhf.2020.0004","volume":"2","author":"V Regitz-Zagrosek","year":"2020","unstructured":"Regitz-Zagrosek V. Sex and gender differences in heart failure. Int J Heart Fail. 2020;2(3):157. https:\/\/doi.org\/10.36628\/ijhf.2020.0004.","journal-title":"Int J Heart Fail"},{"key":"2788_CR11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.63425","author":"S H\u00e4gg","year":"2021","unstructured":"H\u00e4gg S, Jylh\u00e4v\u00e4 J. Sex differences in biological aging with a focus on human studies. Elife. 2021. https:\/\/doi.org\/10.7554\/eLife.63425.","journal-title":"Elife"},{"issue":"9","key":"2788_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s44161-022-00131-8","volume":"1","author":"DV Zhernakova","year":"2022","unstructured":"Zhernakova DV, Sinha T, Andreu-S\u00e1nchez S, Prins JR, Kurilshikov A, Balder J-W, Sanna S, Franke L, Kuivenhoven JA, Zhernakova A, Fu J. Age-dependent sex differences in cardiometabolic risk factors. Nat Cardiovasc Res. 2022;1(9):844\u201354. https:\/\/doi.org\/10.1038\/s44161-022-00131-8.","journal-title":"Nat Cardiovasc Res"},{"key":"2788_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003609","author":"MJ Gurka","year":"2016","unstructured":"Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc. 2016. https:\/\/doi.org\/10.1161\/JAHA.116.003609.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"2788_CR14","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/ijms24021588","volume":"24","author":"A Meloni","year":"2023","unstructured":"Meloni A, Cadeddu C, Cugusi L, Donataccio MP, Deidda M, Sciomer S, Gallina S, Vassalle C, Moscucci F, Mercuro G, Maffei S. Gender differences and cardiometabolic risk: the importance of the risk factors. Int J Mol Sci. 2023;24(2):1588. https:\/\/doi.org\/10.3390\/ijms24021588.","journal-title":"Int J Mol Sci"},{"key":"2788_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/17455057221140209","author":"G Kaur","year":"2022","unstructured":"Kaur G, Lau E. Sex differences in heart failure with preserved ejection fraction: from traditional risk factors to sex-specific risk factors. Women\u2019s Health. 2022. https:\/\/doi.org\/10.1177\/17455057221140209.","journal-title":"Women\u2019s Health"},{"issue":"8","key":"2788_CR16","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/ejhf.3284","volume":"26","author":"GMC Rosano","year":"2024","unstructured":"Rosano GMC, Stolfo D, Anderson L, et al. Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC. Eur J Heart Fail. 2024;26(8):1669\u201386. https:\/\/doi.org\/10.1002\/ejhf.3284.","journal-title":"Eur J Heart Fail"},{"key":"2788_CR17","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2022.06","author":"K Teramoto","year":"2022","unstructured":"Teramoto K, Teng T-HK, Chandramouli C, Tromp J, Sakata Y, Lam CS. Epidemiology and clinical features of heart failure with preserved ejection fraction. Cardiac Fail Rev. 2022. https:\/\/doi.org\/10.15420\/cfr.2022.06.","journal-title":"Cardiac Fail Rev"},{"issue":"7","key":"2788_CR18","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"SD Anker","year":"2023","unstructured":"Anker SD, Usman MS, Anker MS, et al. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the heart failure association, the European heart rhythm association of the European society of cardiology, and the European society of hypertension. Eur J Heart Fail. 2023;25(7):936\u201355. https:\/\/doi.org\/10.1002\/ejhf.2894.","journal-title":"Eur J Heart Fail"},{"issue":"37","key":"2788_CR19","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195.","journal-title":"Eur Heart J"},{"issue":"3","key":"2788_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","volume":"131","author":"SJ Shah","year":"2015","unstructured":"Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, Bonow RO, Huang C-C, Deo RC. Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation. 2015;131(3):269\u201379. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010637.","journal-title":"Circulation"},{"issue":"3","key":"2788_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","volume":"8","author":"JB Cohen","year":"2020","unstructured":"Cohen JB, Schrauben SJ, Zhao L, Basso MD, Cvijic ME, Li Z, Yarde M, Wang Z, Bhattacharya PT, Chirinos DA, Prenner S, Zamani P, Seiffert DA, Car BD, Gordon DA, Margulies K, Cappola T, Chirinos JA. Clinical phenogroups in heart\u00a0failure with preserved ejection fraction. JAC: Heart Fail. 2020;8(3):172\u201384. https:\/\/doi.org\/10.1016\/j.jchf.2019.09.009.","journal-title":"JAC: Heart Fail"},{"issue":"5","key":"2788_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","volume":"106","author":"\u00c5K Hedman","year":"2020","unstructured":"Hedman \u00c5K, Hage C, Sharma A, Brosnan MJ, Buckbinder L, Gan L-M, Shah SJ, Linde CM, Donal E, Daubert J-C, M\u00e4larstig A, Ziemek D, Lund L. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning. Heart. 2020;106(5):342\u20139. https:\/\/doi.org\/10.1136\/heartjnl-2019-315481.","journal-title":"Heart"},{"issue":"9","key":"2788_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ejhf.327","volume":"17","author":"DP Kao","year":"2015","unstructured":"Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE, McKelvie RS, Komajda M, McMurray JJ, Lindenfeld J. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. Eur J Heart Fail. 2015;17(9):925\u201335. https:\/\/doi.org\/10.1002\/ejhf.327.","journal-title":"Eur J Heart Fail"},{"key":"2788_CR24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027689","author":"R Nakamaru","year":"2023","unstructured":"Nakamaru R, Shiraishi Y, Niimi N, Kohno T, Nagatomo Y, Takei M, Ikoma T, Nishikawa K, Sakamoto M, Nakano S, Kohsaka S, Yoshikawa T. Phenotyping of elderly patients with heart failure focused on noncardiac conditions: a latent class analysis from a multicenter registry of patients hospitalized with heart failure. J Am Heart Assoc. 2023. https:\/\/doi.org\/10.1161\/JAHA.122.027689.","journal-title":"J Am Heart Assoc"},{"key":"2788_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oead133","author":"M Pierre-Jean","year":"2023","unstructured":"Pierre-Jean M, Marut B, Curtis E, Galli E, Cuggia M, Bouzill\u00e9 G, Donal E. Phenotyping of heart failure with preserved ejection faction using electronic health records and echocardiography. Eur Heart J Open. 2023. https:\/\/doi.org\/10.1093\/ehjopen\/oead133.","journal-title":"Eur Heart J Open"},{"issue":"6\u20137","key":"2788_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.acvd.2020.03.012","volume":"113","author":"F Schrub","year":"2020","unstructured":"Schrub F, Oger E, Bidaut A, Hage C, Charton M, Daubert JC, Leclercq C, Linde C, Lund L, Donal E. Heart failure with preserved ejection fraction: a clustering approach to a heterogenous syndrome. Arch Cardiovasc Dis. 2020;113(6\u20137):381\u201390. https:\/\/doi.org\/10.1016\/j.acvd.2020.03.012.","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"2788_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/ejhf.1621","volume":"22","author":"MW Segar","year":"2020","unstructured":"Segar MW, Patel KV, Ayers C, Basit M, Tang WHW, Willett D, Berry J, Grodin JL, Pandey A. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis. Eur J Heart Fail. 2020;22(1):148\u201358. https:\/\/doi.org\/10.1002\/ejhf.1621.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"2788_CR28","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1136\/heartjnl-2021-320270","volume":"108","author":"Y Sotomi","year":"2022","unstructured":"Sotomi Y, Hikoso S, Komukai S, et al. Phenotyping of acute decompensated heart failure with preserved ejection fraction. Heart. 2022;108(19):1553\u201361. https:\/\/doi.org\/10.1136\/heartjnl-2021-320270.","journal-title":"Heart"},{"issue":"6","key":"2788_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ejhf.2169","volume":"23","author":"A Uijl","year":"2021","unstructured":"Uijl A, Savarese G, Vaartjes I, Dahlstr\u00f6m U, Brugts JJ, Linssen GCM, van Empel V, Brunner-La Rocca H, Asselbergs FW, Lund LH, Hoes AW, Koudstaal S. Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(6):973\u201382. https:\/\/doi.org\/10.1002\/ejhf.2169.","journal-title":"Eur J Heart Fail"},{"key":"2788_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcae067","author":"L Vicent","year":"2024","unstructured":"Vicent L, Rosillo N, V\u00e9lez J, Moreno G, P\u00e9rez P, Bernal JL, Seara G, Salguero-Bodes R, Arribas F, Bueno H. Profiling heart failure with preserved or mildly reduced ejection fraction by cluster analysis. Eur Heart J\u2014Qual Care Clin Outcomes. 2024. https:\/\/doi.org\/10.1093\/ehjqcco\/qcae067.","journal-title":"Eur Heart J\u2014Qual Care Clin Outcomes"},{"issue":"6","key":"2788_CR31","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ejhf.2144","volume":"23","author":"RJ Woolley","year":"2021","unstructured":"Woolley RJ, Ceelen D, Ouwerkerk W, Tromp J, Figarska SM, Anker SD, Dickstein K, Filippatos G, Zannad F, Metra M, Ng L, Samani N, van Veldhuisen DJ, Lang C, Lam CS, Voors AA. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(6):983\u201391. https:\/\/doi.org\/10.1002\/ejhf.2144.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2788_CR32","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/ejhf.2947","volume":"25","author":"A Brann","year":"2023","unstructured":"Brann A, Miller J, Eshraghian E, Park JJ, Greenberg B. Global longitudinal strain predicts clinical outcomes in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2023;25(10):1755\u201365. https:\/\/doi.org\/10.1002\/ejhf.2947.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"2788_CR33","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/ejhf.754","volume":"19","author":"AD DeVore","year":"2017","unstructured":"DeVore AD, McNulty S, Alenezi F, Ersboll M, Vader JM, Oh JK, Lin G, Redfield MM, Lewis G, Semigran MJ, Anstrom KJ, Hernandez AF, Velazquez EJ. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the <scp>RELAX<\/scp> trial. Eur J Heart Fail. 2017;19(7):893\u2013900. https:\/\/doi.org\/10.1002\/ejhf.754.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"2788_CR34","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/s41598-018-19507-7","volume":"8","author":"F Duca","year":"2018","unstructured":"Duca F, Zotter-Tufaro C, Kammerlander AA, Aschauer S, Binder C, Mascherbauer J, Bonderman D. Gender-related differences in heart failure with preserved ejection fraction. Sci Rep. 2018;8(1):1080. https:\/\/doi.org\/10.1038\/s41598-018-19507-7.","journal-title":"Sci Rep"},{"issue":"5","key":"2788_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ejhf.67","volume":"16","author":"M Gori","year":"2014","unstructured":"Gori M, Lam CSP, Gupta DK, Santos ABS, Cheng S, Shah AM, Claggett B, Zile MR, Kraigher-Krainer E, Pieske B, Voors AA, Packer M, Bransford T, Lefkowitz M, McMurray JJV, Solomon SD. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16(5):535\u201342. https:\/\/doi.org\/10.1002\/ejhf.67.","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"2788_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.122.062874","volume":"147","author":"F Capone","year":"2023","unstructured":"Capone F, Vettor R, Schiattarella GG. Cardiometabolic HFpEF: NASH of the Heart. Circulation. 2023;147(6):451\u20133. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062874.","journal-title":"Circulation"},{"issue":"39","key":"2788_CR37","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","volume":"44","author":"N Marx","year":"2023","unstructured":"Marx N, Federici M, Sch\u00fctt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes: developed by the task force on the management of cardiovascular disease in patients with diabetes of the European Society of Cardiology (ESC). Eur Heart J. 2023;44(39):4043\u2013140. https:\/\/doi.org\/10.1093\/eurheartj\/ehad192.","journal-title":"Eur Heart J"},{"issue":"2","key":"2788_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jacc.2024.05.005","volume":"84","author":"JW Ostrominski","year":"2024","unstructured":"Ostrominski JW, Claggett BL, Miao ZM, Mc Causland FR, Anand IS, Desai AS, Jhund PS, Lam CSP, Pfeffer MA, Pitt B, Zannad F, Zile MR, Bomfim Wirtz A, Lay-Flurrie J, Viswanathan P, McMurray JJV, Solomon SD, Vaduganathan M. Cardiovascular-kidney-metabolic overlap in heart failure with mildly reduced or preserved ejection fraction. J Am Coll Cardiol. 2024;84(2):223\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.005.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2788_CR39","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1161\/CIRCULATIONAHA.119.041886","volume":"141","author":"SJ Shah","year":"2020","unstructured":"Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R, Chirinos JA, Collins S, Deo RC, Gladwin MT, Granzier H, Hummel SL, Kass DA, Redfield MM, Sam F, Wang TJ, Desvigne-Nickens P, Adhikari BB. Research priorities for heart failure with preserved ejection fraction. Circulation. 2020;141(12):1001\u201326. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.041886.","journal-title":"Circulation"},{"key":"2788_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf4428","author":"NE Allen","year":"2024","unstructured":"Allen NE, Lacey B, Lawlor DA, Pell JP, Gallacher J, Smeeth L, Elliott P, Matthews PM, Lyons RA, Whetton AD, Lucassen A, Hurles ME, Chapman M, Roddam AW, Fitzpatrick NK, Hansell AL, Hardy R, Marioni RE, O\u2019Donnell VB, Collins R. Prospective study design and data analysis in UK biobank. Sci Transl Med. 2024. https:\/\/doi.org\/10.1126\/scitranslmed.adf4428.","journal-title":"Sci Transl Med"},{"issue":"1","key":"2788_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12968-017-0327-9","volume":"19","author":"SE Petersen","year":"2016","unstructured":"Petersen SE, Aung N, Sanghvi MM, Zemrak F, Fung K, Paiva JM, Francis JM, Khanji MY, Lukaschuk E, Lee AM, Carapella V, Kim YJ, Leeson P, Piechnik SK, Neubauer S. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J Cardiovasc Magn Reson. 2016;19(1):18. https:\/\/doi.org\/10.1186\/s12968-017-0327-9.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"2788_CR42","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12968-016-0227-4","volume":"18","author":"SE Petersen","year":"2016","unstructured":"Petersen SE, Matthews PM, Francis JM, Robson MD, Zemrak F, Boubertakh R, Young AA, Hudson S, Weale P, Garratt S, Collins R, Piechnik S, Neubauer S. UK Biobank\u2019s cardiovascular magnetic resonance protocol. J Cardiovasc Magn Reson. 2016;18(1):8. https:\/\/doi.org\/10.1186\/s12968-016-0227-4.","journal-title":"J Cardiovasc Magn Reson"},{"key":"2788_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011366","author":"LB Kosyakovsky","year":"2024","unstructured":"Kosyakovsky LB, Liu EE, Wang JK, Myers L, Parekh JK, Knauss H, Lewis GD, Malhotra R, Nayor M, Robbins JM, Gerszten RE, Hamburg NM, McNeill JN, Lau ES, Ho JE. Uncovering unrecognized heart failure with preserved ejection fraction among individuals with obesity and dyspnea. Circ: Heart Fail. 2024. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.123.011366.","journal-title":"Circ: Heart Fail"},{"issue":"2","key":"2788_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10741-019-09836-8","volume":"25","author":"S Loai","year":"2020","unstructured":"Loai S, Cheng H-LM. Heart failure with preserved ejection fraction: the missing pieces in diagnostic imaging. Heart Fail Rev. 2020;25(2):305\u201319. https:\/\/doi.org\/10.1007\/s10741-019-09836-8.","journal-title":"Heart Fail Rev"},{"issue":"38","key":"2788_CR45","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"issue":"9","key":"2788_CR46","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30(9):2395\u20139. https:\/\/doi.org\/10.1038\/s41591-024-03095-3.","journal-title":"Nat Med"},{"issue":"10","key":"2788_CR47","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/s41591-020-1009-y","volume":"26","author":"W Bai","year":"2020","unstructured":"Bai W, Suzuki H, Huang J, Francis C, Wang S, Tarroni G, Guitton F, Aung N, Fung K, Petersen SE, Piechnik SK, Neubauer S, Evangelou E, Dehghan A, O\u2019Regan DP, Wilkins MR, Guo Y, Matthews PM, Rueckert D. A population-based phenome-wide association study of cardiac and aortic structure and function. Nat Med. 2020;26(10):1654\u201362. https:\/\/doi.org\/10.1038\/s41591-020-1009-y.","journal-title":"Nat Med"},{"issue":"1","key":"2788_CR48","doi-asserted-by":"publisher","first-page":"e190032","DOI":"10.1148\/ryct.2020190032","volume":"2","author":"E Ferdian","year":"2020","unstructured":"Ferdian E, Suinesiaputra A, Fung K, Aung N, Lukaschuk E, Barutcu A, Maclean E, Paiva J, Piechnik SK, Neubauer S, Petersen SE, Young AA. Fully automated myocardial strain estimation from cardiovascular mri\u2013tagged images using a deep learning framework in the UK biobank. Radiol: Cardiothorac Imag. 2020;2(1):e190032. https:\/\/doi.org\/10.1148\/ryct.2020190032.","journal-title":"Radiol: Cardiothorac Imag"},{"issue":"1","key":"2788_CR49","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/CCM.0000000000004710","volume":"49","author":"P Sinha","year":"2021","unstructured":"Sinha P, Calfee CS, Delucchi KL. Practitioner\u2019s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med. 2021;49(1):e63\u201379. https:\/\/doi.org\/10.1097\/CCM.0000000000004710.","journal-title":"Crit Care Med"},{"issue":"2","key":"2788_CR50","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","volume":"68","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, Shah SJ. The HFpEF obesity phenotype. J Am Coll Cardiol. 2016;68(2):200\u20133. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.019.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2788_CR51","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","volume":"329","author":"MM Redfield","year":"2023","unstructured":"Redfield MM, Borlaug BA. Heart failure with preserved ejection fraction. JAMA. 2023;329(10):827. https:\/\/doi.org\/10.1001\/jama.2023.2020.","journal-title":"JAMA"},{"issue":"6","key":"2788_CR52","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/ejhf.1788","volume":"22","author":"YNV Reddy","year":"2020","unstructured":"Reddy YNV, Rikhi A, Obokata M, Shah SJ, Lewis GD, AbouEzzedine OF, Dunlay S, McNulty S, Chakraborty H, Stevenson LW, Redfield MM, Borlaug BA. Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity. Eur J Heart Fail. 2020;22(6):1009\u201318. https:\/\/doi.org\/10.1002\/ejhf.1788.","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"2788_CR53","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos JP, et al. Empagliflozin in heart failure with a preserved ejection fraction. New Engl J Med. 2021;385(16):1451\u201361. https:\/\/doi.org\/10.1056\/NEJMoa2107038.","journal-title":"New Engl J Med"},{"issue":"7","key":"2788_CR54","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ejhf.2249","volume":"23","author":"SD Solomon","year":"2021","unstructured":"Solomon SD, de Boer RA, DeMets D, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez F, Shah SJ, Lindholm D, Wilder\u00e4ng U, \u00d6hrn F, Claggett B, Langkilde AM, Petersson M, McMurray JJV. Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial. Eur J Heart Fail. 2021;23(7):1217\u201325. https:\/\/doi.org\/10.1002\/ejhf.2249.","journal-title":"Eur J Heart Fail"},{"issue":"41","key":"2788_CR55","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1093\/eurheartj\/ehac481","volume":"43","author":"C Adamson","year":"2022","unstructured":"Adamson C, Kondo T, Jhund PS, de Boer RA, Cabrera Honorio JW, Claggett B, Desai AS, Alcocer Gamba MA, Al Habeeb W, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Langkilde AM, Lindholm D, Bachus E, Litwin SE, Martinez F, Petersson M, McMurray JJV. Dapagliflozin for heart failure according to body mass index: the DELIVER trial. Eur Heart J. 2022;43(41):4406\u201317. https:\/\/doi.org\/10.1093\/eurheartj\/ehac481.","journal-title":"Eur Heart J"},{"issue":"22","key":"2788_CR56","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.jacc.2016.08.072","volume":"68","author":"S Carbone","year":"2016","unstructured":"Carbone S, Canada JM, Buckley LF, Trankle CR, Dixon DL, Buzzetti R, Arena R, Van Tassell BW, Abbate A. Obesity contributes to exercise intolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol. 2016;68(22):2487\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.072.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2788_CR57","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.mayocp.2018.11.037","volume":"94","author":"YNV Reddy","year":"2019","unstructured":"Reddy YNV, Lewis GD, Shah SJ, Obokata M, Abou-Ezzedine OF, Fudim M, Sun J-L, Chakraborty H, McNulty S, LeWinter MM, Mann DL, Stevenson LW, Redfield MM, Borlaug BA. Characterization of the obese phenotype of heart failure with preserved ejection fraction: a RELAX trial ancillary study. Mayo Clin Proc. 2019;94(7):1199\u2013209. https:\/\/doi.org\/10.1016\/j.mayocp.2018.11.037.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"2788_CR58","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, Collins R, Allen NE. Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334. https:\/\/doi.org\/10.1093\/aje\/kwx246.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2788_CR59","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamacardio.2019.4150","volume":"5","author":"ES Lau","year":"2020","unstructured":"Lau ES, Cunningham T, Hardin KM, Liu E, Malhotra R, Nayor M, Lewis GD, Ho JE. Sex differences in cardiometabolic traits and determinants of exercise capacity in heart failure with preserved ejection fraction. JAMA Cardiol. 2020;5(1):30. https:\/\/doi.org\/10.1001\/jamacardio.2019.4150.","journal-title":"JAMA Cardiol"},{"key":"2788_CR60","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018574","author":"Y Sotomi","year":"2021","unstructured":"Sotomi Y, Hikoso S, Nakatani D, Mizuno H, Okada K, Dohi T, Kitamura T, Sunaga A, Kida H, Oeun B, Sato T, Komukai S, Tamaki S, Yano M, Hayashi T, Nakagawa A, Nakagawa Y, Yasumura Y, Yamada T, Sakata Y. Sex differences in heart failure with preserved ejection fraction. J Am Heart Assoc. 2021. https:\/\/doi.org\/10.1161\/JAHA.120.018574.","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"2788_CR61","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","volume":"55","author":"LJM Boonman-de Winter","year":"2012","unstructured":"Boonman-de Winter LJM, Rutten FH, Cramer MJM, Landman MJ, Liem AH, Rutten GEHM, Hoes AW. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012;55(8):2154\u201362. https:\/\/doi.org\/10.1007\/s00125-012-2579-0.","journal-title":"Diabetologia"},{"issue":"4","key":"2788_CR62","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s00125-023-06068-2","volume":"67","author":"AG Hoek","year":"2024","unstructured":"Hoek AG, Dal Canto E, Wenker E, Bindraban N, Handoko ML, Elders PJM, Beulens JWJ. Epidemiology of heart failure in diabetes: a disease in disguise. Diabetologia. 2024;67(4):574\u2013601. https:\/\/doi.org\/10.1007\/s00125-023-06068-2.","journal-title":"Diabetologia"},{"key":"2788_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1130618","author":"J Malik","year":"2023","unstructured":"Malik J, Valerianova A, Pesickova SS, Michalickova K, Hladinova Z, Hruskova Z, Bednarova V, Rocinova K, Tothova M, Kratochvilova M, Kaiserova L, Buryskova Salajova K, Lejsek V, Sevcik M, Tesar V. Heart failure with preserved ejection fraction is the most frequent but commonly overlooked phenotype in patients on chronic hemodialysis. Front Cardiovasc Med. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1130618.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"2788_CR64","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-018-0756-2","volume":"17","author":"P Blomstrand","year":"2018","unstructured":"Blomstrand P, Sj\u00f6blom P, Nilsson M, Wijkman M, Engvall M, L\u00e4nne T, Nystr\u00f6m FH, \u00d6stgren CJ, Engvall J. Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain. Cardiovasc Diabetol. 2018;17(1):113. https:\/\/doi.org\/10.1186\/s12933-018-0756-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"2788_CR65","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.rec.2017.10.008","volume":"71","author":"W Ca\u00f1on-Monta\u00f1ez","year":"2018","unstructured":"Ca\u00f1on-Monta\u00f1ez W, Santos ABS, Nunes LA, Pires JCG, Freire CMV, Ribeiro ALP, Mill JG, Bessel M, Duncan BB, Schmidt MI, Foppa M. Central obesity is the key component in the association of metabolic syndrome with left ventricular global longitudinal strain impairment. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition). 2018;71(7):524\u201330. https:\/\/doi.org\/10.1016\/j.rec.2017.10.008.","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"2788_CR66","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.035781","author":"ES Lau","year":"2024","unstructured":"Lau ES, Zhao Y, Benjamin EJ, Ramachandran VS, Xanthakis V, Cheng S, Ho JE. Sex differences in left ventricular function and cardiac mechanics. J Am Heart Assoc. 2024. https:\/\/doi.org\/10.1161\/JAHA.124.035781.","journal-title":"J Am Heart Assoc"},{"key":"2788_CR67","doi-asserted-by":"publisher","first-page":"131886","DOI":"10.1016\/j.ijcard.2024.131886","volume":"403","author":"Y-H Wang","year":"2024","unstructured":"Wang Y-H, Sun L, Li S-W, et al. Left ventricular global longitudinal strain using a novel fully automated method: a head-to-head comparison with a manual layer-specific strain and establishment of normal reference ranges. Int J Cardiol. 2024;403:131886. https:\/\/doi.org\/10.1016\/j.ijcard.2024.131886.","journal-title":"Int J Cardiol"},{"issue":"10","key":"2788_CR68","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1007\/s10554-020-01906-5","volume":"36","author":"KG Skaarup","year":"2020","unstructured":"Skaarup KG, Lassen MCH, Marott JL, Biering-S\u00f8rensen SR, J\u00f8rgensen PG, Appleyard M, Berning J, H\u00f8st N, Jensen G, Schnohr P, S\u00f8gaard P, Gislason G, M\u00f8gelvang R, Biering-S\u00f8rensen T. The impact of cardiovascular risk factors on global longitudinal strain over a decade in the general population: the copenhagen city heart study. Int J Cardiovasc Imaging. 2020;36(10):1907\u201316. https:\/\/doi.org\/10.1007\/s10554-020-01906-5.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"7","key":"2788_CR69","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/eurjhf\/hft026","volume":"15","author":"MM Abudiab","year":"2013","unstructured":"Abudiab MM, Redfield MM, Melenovsky V, Olson TP, Kass DA, Johnson BD, Borlaug BA. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013;15(7):776\u201385. https:\/\/doi.org\/10.1093\/eurjhf\/hft026.","journal-title":"Eur J Heart Fail"},{"issue":"21","key":"2788_CR70","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/CIRCULATIONAHA.121.054858","volume":"144","author":"MK Burrage","year":"2021","unstructured":"Burrage MK, Hundertmark M, Valkovi\u010d L, Watson WD, Rayner J, Sabharwal N, Ferreira VM, Neubauer S, Miller JJ, Rider OJ, Lewis AJM. Energetic basis for exercise-induced pulmonary congestion in heart failure with preserved ejection fraction. Circulation. 2021;144(21):1664\u201378. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.054858.","journal-title":"Circulation"},{"issue":"1","key":"2788_CR71","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","volume":"73","author":"K Omote","year":"2022","unstructured":"Omote K, Verbrugge FH, Borlaug BA. Heart failure with preserved ejection fraction: mechanisms and treatment strategies. Annu Rev Med. 2022;73(1):321\u201337. https:\/\/doi.org\/10.1146\/annurev-med-042220-022745.","journal-title":"Annu Rev Med"},{"issue":"5","key":"2788_CR72","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jacc.2016.05.043","volume":"68","author":"YNV Reddy","year":"2016","unstructured":"Reddy YNV, Melenovsky V, Redfield MM, Nishimura RA, Borlaug BA. High-output heart failure. J Am Coll Cardiol. 2016;68(5):473\u201382. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.043.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2788_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ejhf.3092","volume":"26","author":"SE Litwin","year":"2024","unstructured":"Litwin SE, Komtebedde J, Seidler T, et al. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial. Eur J Heart Fail. 2024;26(1):177\u201389. https:\/\/doi.org\/10.1002\/ejhf.3092.","journal-title":"Eur J Heart Fail"},{"key":"2788_CR74","doi-asserted-by":"publisher","unstructured":"Hyson PR, Kao DP. Biomarkers correspond with echocardiographic phenotypes in heart failure with preserved ejection fraction: a secondary analysis of the RELAX Trial. 2024. https:\/\/doi.org\/10.1101\/2024.04.30.24306660.","DOI":"10.1101\/2024.04.30.24306660"},{"key":"2788_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00316-4","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2788_CR76","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/d41573-022-00158-3","volume":"21","author":"SJ Shah","year":"2022","unstructured":"Shah SJ, Butler J, Shah SH, Kamphaus TN, Sachdev V. Accelerating therapeutic discoveries for heart failure: a new public\u2013private partnership. Nat Rev Drug Discovery. 2022;21(11):781\u20132. https:\/\/doi.org\/10.1038\/d41573-022-00158-3.","journal-title":"Nat Rev Drug Discovery"},{"key":"2788_CR77","unstructured":"Shah S, Kho A, Luo Y, Scholtens D. HeartShare Deep Phenotyping Study Protocol v. 2.3. 2024."},{"issue":"5","key":"2788_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1136\/heartjnl-2023-323049","volume":"110","author":"UK HFpEF Collaborative Group","year":"2024","unstructured":"UK HFpEF Collaborative Group. Rationale and design of the United Kingdom heart failure with preserved ejection fraction registry. Heart. 2024;110(5):359\u201365. https:\/\/doi.org\/10.1136\/heartjnl-2023-323049.","journal-title":"Heart"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02788-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02788-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02788-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T14:39:18Z","timestamp":1749047958000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02788-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2788"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02788-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TM is employed by Novo Nordisk Research Centre Oxford Ltd. RG consults for Novo Nordisk A\/S. TM and RG own minor Novo Nordisk company stock.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}